Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Cancer Res. 2010 Jul 27;70(17):6902–6912. doi: 10.1158/0008-5472.CAN-10-1440

Figure 3.

Figure 3

Pharmacokinetic analysis of ICT2588 following intraperitoneal administration to HT1080 tumor bearing mice. Analysis by LCMS of (A) ICT2588 and (B) the authentic metabolite produced from hydrolysis of ICT2588 (ICT2552act). Each time point represents the mean of 3 mice ± SD.